NCT01947790View on ClinicalTrials.gov

Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
LVMType 2 Diabetic Patients With IHDEndothelial Function
Interventions
DRUG

pioglitazone group

DRUG

Metformin group

Trial Locations (2)

43000

Wuhan

430070

Xiang Guangda, Wuhan

All Listed Sponsors
lead

Xiang Guang-da

OTHER

NCT01947790 - Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease | Biotech Hunter | Biotech Hunter